Insider · CIK 0001927831
Kalia Kumud
officer
Files at GH (Guardant Health, Inc.). First filing Nov 19, 2024, latest Nov 19, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $205k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 52Moderate | sell 3 | GH Guardant Health, Inc. | $205k | 7,000 | -28% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 15, 2024 | GH Guardant Health, Inc. | MOption exercise Common Stock | +637 | $0.00 | $0 | 18,731 | Dec 16, 2024 |
| Dec 15, 2024 | GH Guardant Health, Inc. | FTax withholding Common Stock | -323 | $34.76 | $11k | 18,408 | Dec 16, 2024 |
| Dec 15, 2024 | GH Guardant Health, Inc. | MOption exercise Restricted Stock Unitsderivative | -637 | $0.00 | $0 | 3,824 | Dec 16, 2024 |
| Dec 1, 2024 | GH Guardant Health, Inc. | MOption exercise Common Stock | +710 | $0.00 | $0 | 18,454 | Dec 2, 2024 |
| Dec 1, 2024 | GH Guardant Health, Inc. | FTax withholding Common Stock | -360 | $35.61 | $13k | 18,094 | Dec 2, 2024 |
| Dec 1, 2024 | GH Guardant Health, Inc. | MOption exercise Restricted Stock Unitsderivative | -710 | $0.00 | $0 | 2,131 | Dec 2, 2024 |
| Nov 18, 2024 | GH Guardant Health, Inc. | SOpen-market sale Common Stock | -7,000 | $29.25 | $205k | 17,744 | Nov 19, 2024 |
| Nov 8, 2024 | GH Guardant Health, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +35,721 | $0.00 | $0 | 35,721 | Nov 12, 2024 |
| Nov 8, 2024 | GH Guardant Health, Inc. | AGrant or award Restricted Stock Unitsderivative | +23,814 | $0.00 | $0 | 23,814 | Nov 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.